Platelets in Pregnancy

NCT06194643 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2025-09-18

No results posted yet for this study

Summary

This is a prospective observational cohort study of platelet phenotype in pregnant patients at high-risk for the development preeclampsia. Blood samples will be collected prior to the initiation of daily aspirin and again in the second trimester to evaluate for platelet changes during pregnancy in patient's as a result of aspirin use and their association with adverse perinatal outcomes.

Conditions

  • Hypertensive Disorder of Pregnancy

Sponsors & Collaborators

Principal Investigators

  • Christina A. Penfield, MD, MPH · NYU Langone Health

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-17
Primary Completion
2025-01-08
Completion
2026-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06194643 on ClinicalTrials.gov